Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 81

1.

Left Ventricular Structure in Patients With Mild-to-Moderate CKD-a Magnetic Resonance Imaging Study.

Schneider MP, Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Störk S, Wanner C, Schlieper G, Saritas T, Reinartz SD, Floege J, Friedrich N, Janka R, Uder M, Schmieder RE, Eckardt KU.

Kidney Int Rep. 2018 Oct 11;4(2):267-274. doi: 10.1016/j.ekir.2018.10.004. eCollection 2019 Feb.

2.

Blood Pressure Pattern and Target Organ Damage in Patients With Chronic Kidney Disease.

Scheppach JB, Raff U, Toncar S, Ritter C, Klink T, Störk S, Wanner C, Schlieper G, Saritas T, Reinartz SD, Floege J, Janka R, Uder M, Schmieder RE, Eckardt KU, Schneider MP.

Hypertension. 2018 Oct;72(4):929-936. doi: 10.1161/HYPERTENSIONAHA.118.11608.

PMID:
30354716
3.

Retinal capillary and arteriolar changes in patients with chronic kidney disease.

Bosch A, Scheppach JB, Harazny JM, Raff U, Eckardt KU, Schmieder RE, Schneider MP.

Microvasc Res. 2018 Jul;118:121-127. doi: 10.1016/j.mvr.2018.03.008. Epub 2018 Mar 17.

PMID:
29559377
4.

Low dose-eplerenone treatment decreases aortic stiffness in patients with resistant hypertension.

Kalizki T, Schmidt BMW, Raff U, Reinold A, Schwarz TK, Schneider MP, Schmieder RE, Schneider A.

J Clin Hypertens (Greenwich). 2017 Jul;19(7):669-676. doi: 10.1111/jch.12986. Epub 2017 Feb 17.

5.

Increased Aldosterone Release During Head-Up Tilt in Early Primary Hypertension.

Reinold A, Schneider A, Kalizki T, Raff U, Schneider MP, Schmieder RE, Schmidt BMW.

Am J Hypertens. 2017 May 1;30(5):484-489. doi: 10.1093/ajh/hpw199.

PMID:
28200011
6.

Skin Sodium Concentration Correlates with Left Ventricular Hypertrophy in CKD.

Schneider MP, Raff U, Kopp C, Scheppach JB, Toncar S, Wanner C, Schlieper G, Saritas T, Floege J, Schmid M, Birukov A, Dahlmann A, Linz P, Janka R, Uder M, Schmieder RE, Titze JM, Eckardt KU.

J Am Soc Nephrol. 2017 Jun;28(6):1867-1876. doi: 10.1681/ASN.2016060662. Epub 2017 Feb 2.

7.

Hepcidin-25 in diabetic chronic kidney disease is predictive for mortality and progression to end stage renal disease.

Wagner M, Ashby DR, Kurtz C, Alam A, Busbridge M, Raff U, Zimmermann J, Heuschmann PU, Wanner C, Schramm L.

PLoS One. 2015 Apr 20;10(4):e0123072. doi: 10.1371/journal.pone.0123072. eCollection 2015.

8.

Olmesartan improves pulse wave velocity and lowers central systolic blood pressure and ambulatory blood pressure in patients with metabolic syndrome.

Raff U, Walker S, Ott C, Schneider MP, Schmieder RE.

J Clin Hypertens (Greenwich). 2015 Feb;17(2):98-104. doi: 10.1111/jch.12458. Epub 2014 Dec 24.

9.

Prevention of electrocardiographic left ventricular remodeling by the angiotensin receptor blocker olmesartan in patients with type 2 diabetes.

Raff U, Ott C, Ruilope LM, Menne J, Haller H, Schmieder RE.

J Hypertens. 2014 Nov;32(11):2267-76; discussion 2276. doi: 10.1097/HJH.0000000000000313.

PMID:
25275251
10.

First experience in analysing pulsatile retinal capillary flow and arteriolar structural parameters measured noninvasively in hypertensive patients.

Harazny JM, Ott C, Raff U, Welzenbach J, Kwella N, Michelson G, Schmieder RE.

J Hypertens. 2014 Nov;32(11):2246-52; discussion 2252. doi: 10.1097/HJH.0000000000000308.

PMID:
25101652
11.

Is the fastest MRI a hologram?

Hutchinson M, Raff U.

J Neuroimaging. 2014 Nov-Dec;24(6):537-542. doi: 10.1111/jon.12141. Epub 2014 Jul 15. Review.

PMID:
25040232
12.

Circadian rhythm and day to day variability of serum potassium concentration: a pilot study.

Schmidt ST, Ditting T, Deutsch B, Schutte R, Friedrich S, Kistner I, Ott C, Raff U, Veelken R, Schmieder RE.

J Nephrol. 2015 Apr;28(2):165-72. doi: 10.1007/s40620-014-0115-7. Epub 2014 Jul 3.

PMID:
24990164
13.

Spin-lattice distribution MRI maps nigral pathology in progressive supranuclear palsy (PSP) during life: a pilot study.

Hutchinson M, Raff U, Chaná P, Huete I.

PLoS One. 2014 Jan 28;9(1):e85194. doi: 10.1371/journal.pone.0085194. eCollection 2014.

14.

Effects of saxagliptin on early microvascular changes in patients with type 2 diabetes.

Ott C, Raff U, Schmidt S, Kistner I, Friedrich S, Bramlage P, Harazny JM, Schmieder RE.

Cardiovasc Diabetol. 2014 Jan 14;13:19. doi: 10.1186/1475-2840-13-19.

15.

Central pulse pressure is an independent determinant of vascular remodeling in the retinal circulation.

Ott C, Raff U, Harazny JM, Michelson G, Schmieder RE.

Hypertension. 2013 Jun;61(6):1340-5. doi: 10.1161/HYPERTENSIONAHA.111.00617. Epub 2013 Apr 8.

PMID:
23569083
16.

Haemoglobin and vascular function in the human retinal vascular bed.

Ritt M, Harazny JM, Schmidt S, Raff U, Ott C, Michelson G, Schmieder RE.

J Hypertens. 2013 Apr;31(4):775-81. doi: 10.1097/HJH.0b013e32835e2ab5.

PMID:
23337471
17.

25-hydroxyvitamin D insufficiency is associated with impaired renal endothelial function and both are improved with rosuvastatin treatment.

Ott C, Raff U, Schneider MP, Titze SI, Schmieder RE.

Clin Res Cardiol. 2013 Apr;102(4):299-304. doi: 10.1007/s00392-012-0534-1. Epub 2012 Dec 21.

PMID:
23262496
18.

Effects of manidipine vs. amlodipine on intrarenal haemodynamics in patients with arterial hypertension.

Ott C, Schneider MP, Raff U, Ritt M, Striepe K, Alberici M, Schmieder RE.

Br J Clin Pharmacol. 2013 Jan;75(1):129-35. doi: 10.1111/j.1365-2125.2012.04336.x.

19.

Impaired increase of retinal capillary blood flow to flicker light exposure in arterial hypertension.

Ritt M, Harazny JM, Ott C, Raff U, Bauernschubert P, Lehmann M, Michelson G, Schmieder RE.

Hypertension. 2012 Sep;60(3):871-6. doi: 10.1161/HYPERTENSIONAHA.112.192666. Epub 2012 Jul 9.

PMID:
22777934
20.

[Hypertensive crisis].

Schmieder RE, Raff U.

MMW Fortschr Med. 2012 May 3;154(8):56-7. German. No abstract available.

PMID:
22693759
21.

Salt intake determines retinal arteriolar structure in treatment resistant hypertension independent of blood pressure.

Raff U, Harazny JM, Titze SI, Schmidt BM, Michelson G, Schmieder RE.

Atherosclerosis. 2012 May;222(1):235-40. doi: 10.1016/j.atherosclerosis.2012.02.006. Epub 2012 Feb 10.

PMID:
22386068
22.

Reversibility of the effects of aliskiren in the renal versus systemic circulation.

Schneider MP, Janka R, Ziegler T, Raff U, Ritt M, Ott C, Veelken R, Uder M, Schmieder RE.

Clin J Am Soc Nephrol. 2012 Feb;7(2):258-64. doi: 10.2215/CJN.05870611. Epub 2011 Dec 15.

23.

Postchallenge hyperglycemia is closely related with early vascular damage in overweight and obese patients.

Schneider MP, Ott C, Ritt M, Raff U, Schlaich MP, Schmieder RE.

J Hypertens. 2012 Jan;30(1):147-52. doi: 10.1097/HJH.0b013e32834e38b6.

PMID:
22124180
24.

Influence of blood flow on arteriolar wall-to-lumen ratio in the human retinal circulation in vivo.

Ritt M, Harazny JM, Ott C, Raff U, Lehmann M, Michelson G, Schmieder RE.

Microvasc Res. 2012 Mar;83(2):111-7. doi: 10.1016/j.mvr.2011.10.002. Epub 2011 Oct 19.

PMID:
22036673
25.

Cerebral microangiopathy in treatment-resistant hypertension.

Schmieder RE, Schmidt BM, Raff U, Bramlage P, Dörfler A, Achenbach S, Schwab J, Kolominsky-Rabas P.

J Clin Hypertens (Greenwich). 2011 Aug;13(8):582-7. doi: 10.1111/j.1751-7176.2011.00493.x. Epub 2011 Jul 11.

26.

Endogenous erythropoietin and the association with inflammation and mortality in diabetic chronic kidney disease.

Wagner M, Alam A, Zimmermann J, Rauh K, Koljaja-Batzner A, Raff U, Wanner C, Schramm L.

Clin J Am Soc Nephrol. 2011 Jul;6(7):1573-9. doi: 10.2215/CJN.00380111.

27.

New software analyses increase the reliability of measurements of retinal arterioles morphology by scanning laser Doppler flowmetry in humans.

Harazny JM, Raff U, Welzenbach J, Ott C, Ritt M, Lehmann M, Michelson G, Schmieder RE.

J Hypertens. 2011 Apr;29(4):777-82. doi: 10.1097/HJH.0b013e328343c27a.

PMID:
21297501
28.

Basal nitric oxide activity is an independent determinant of arteriolar structure in the human retinal circulation.

Ritt M, Harazny JM, Ott C, Raff U, Schneider MP, Michelson G, Schmieder RE.

J Hypertens. 2011 Jan;29(1):123-9. doi: 10.1097/HJH.0b013e3283406940.

PMID:
21045732
29.

Folic acid treatment normalizes NOS-dependence of vascular tone in the metabolic syndrome.

Schneider MP, Schlaich MP, Harazny JM, Raff U, Ritt M, Ott C, Schmieder RE.

Obesity (Silver Spring). 2011 May;19(5):960-7. doi: 10.1038/oby.2010.210. Epub 2010 Sep 23.

30.

Lethal varicella-zoster virus reactivation without skin lesions following renal transplantation.

Jantsch J, Schmidt B, Bardutzky J, Bogdan C, Eckardt KU, Raff U.

Nephrol Dial Transplant. 2011 Jan;26(1):365-8. doi: 10.1093/ndt/gfq542. Epub 2010 Sep 3.

PMID:
20817667
31.

Change in augmentation index during NOS inhibition, an index of basal NO production, is an independent determinant of large-artery function.

Schneider MP, Ott C, Raff U, Ritt M, Schmieder RE.

Kidney Blood Press Res. 2010;33(5):343-51. doi: 10.1159/000317516. Epub 2010 Aug 12.

32.

Dihydropyridine calcium antagonists are associated with increased albuminuria in treatment-resistant hypertensives.

Hummel D, Raff U, Schwarz TK, Schneider MP, Schmieder RE, Schmidt BM.

J Nephrol. 2010 Sep-Oct;23(5):563-8.

PMID:
20437398
33.

Nitric oxide and reactive hyperemia: role of location and duration of ischemia.

Raff U, Ott C, John S, Schmidt BM, Fleischmann EH, Schmieder RE.

Am J Hypertens. 2010 Aug;23(8):865-9. doi: 10.1038/ajh.2010.72. Epub 2010 Apr 15.

PMID:
20395940
34.

Renal resistive index--a valid tool to assess renal endothelial function in humans?

Raff U, Schwarz TK, Schmidt BM, Schneider MP, Schmieder RE.

Nephrol Dial Transplant. 2010 Jun;25(6):1869-74. doi: 10.1093/ndt/gfp754. Epub 2010 Feb 8.

PMID:
20142629
35.

Renal resistive index in addition to low-grade albuminuria complements screening for target organ damage in therapy-resistant hypertension.

Raff U, Schmidt BM, Schwab J, Schwarz TK, Achenbach S, Bär I, Schmieder RE.

J Hypertens. 2010 Mar;28(3):608-14. doi: 10.1097/HJH.0b013e32833487b8.

PMID:
20090556
36.

Gender is related to alterations of renal endothelial function in type 2 diabetes.

Schneider MP, Ritt M, Raff U, Ott C, Schmieder RE.

Nephrol Dial Transplant. 2009 Nov;24(11):3354-9. doi: 10.1093/ndt/gfp318. Epub 2009 Jun 30.

PMID:
19567476
37.

Semi-automated assessment of left ventricular mass using transaxial Tc-99m Sestamibi SPECT imaging.

Rojas G, Raff U, Gonzalez P, Jaimovich R, Quintana JC.

Comput Med Imaging Graph. 2009 Jun;33(4):247-55. doi: 10.1016/j.compmedimag.2008.09.006. Epub 2009 Mar 3.

PMID:
19261437
38.

Renal vascular endothelial function in hypertensive patients with type 2 diabetes mellitus.

Ritt M, Ott C, Raff U, Schneider MP, Schuster I, Hilgers KF, Schlaich MP, Schmieder RE.

Am J Kidney Dis. 2009 Feb;53(2):281-9. doi: 10.1053/j.ajkd.2008.10.041. Epub 2008 Dec 19.

PMID:
19100670
39.

Effects of telmisartan and ramipril on adiponectin and blood pressure in patients with type 2 diabetes.

Delles C, Raff U, Mimran A, Fauvel JP, Ruilope LM, Schmieder RE.

Am J Hypertens. 2008 Dec;21(12):1330-6. doi: 10.1038/ajh.2008.297. Epub 2008 Nov 6.

PMID:
18989258
40.

Detection of Parkinson's disease by MRI: Spin-lattice distribution imaging.

Hutchinson M, Raff U.

Mov Disord. 2008 Oct 30;23(14):1991-7. doi: 10.1002/mds.22210.

PMID:
18759364
41.

On false negatives in MRI studies of Parkinson disease.

Hutchinson M, Raff U.

Mov Disord. 2007 Jul 30;22(10):1521-2; author reply 1522. No abstract available.

PMID:
17486623
42.

Image fusion in neuroradiology: three clinical examples including MRI of Parkinson disease.

Rojas GM, Raff U, Quintana JC, Huete I, Hutchinson M.

Comput Med Imaging Graph. 2007 Jan;31(1):17-27. Epub 2006 Dec 5.

PMID:
17150328
44.

L-Arginine does not affect renal morphology and cell survival in ischemic acute renal failure in rats.

Raff U, Schneider R, Gambaryan S, Seibold S, Reber M, Vornberger N, Freund R, Schramm L, Wanner C, Galle J.

Nephron Physiol. 2005;101(3):p39-50. Epub 2005 Jun 30.

PMID:
15990449
45.

MRI correlates of pathology in parkinsonism: segmented inversion recovery ratio imaging (SIRRIM).

Hutchinson M, Raff U, Lebedev S.

Neuroimage. 2003 Nov;20(3):1899-902.

PMID:
14642500
46.

Computer assessment of neurodegeneration in Parkinson disease using data fusion techniques with MR images.

Raff U, Rojas GM, Huete I, Hutchinson M.

Acad Radiol. 2003 Sep;10(9):1036-44.

PMID:
13678093
47.

L-Arginine counteracts nitric oxide deficiency and improves the recovery phase of ischemic acute renal failure in rats.

Schneider R, Raff U, Vornberger N, Schmidt M, Freund R, Reber M, Schramm L, Gambaryan S, Wanner C, Schmidt HH, Galle J.

Kidney Int. 2003 Jul;64(1):216-25.

48.

Oxidized LDL and its compound lysophosphatidylcholine potentiate AngII-induced vasoconstriction by stimulation of RhoA.

Galle J, Mameghani A, Bolz SS, Gambaryan S, Görg M, Quaschning T, Raff U, Barth H, Seibold S, Wanner C, Pohl U.

J Am Soc Nephrol. 2003 Jun;14(6):1471-9.

49.

Differential role of angiotensin II receptor subtypes on endothelial superoxide formation.

Sohn HY, Raff U, Hoffmann A, Gloe T, Heermeier K, Galle J, Pohl U.

Br J Pharmacol. 2000 Oct;131(4):667-72.

50.

Stimulation of NADPH oxidase by oxidized low-density lipoprotein induces proliferation of human vascular endothelial cells.

Heinloth A, Heermeier K, Raff U, Wanner C, Galle J.

J Am Soc Nephrol. 2000 Oct;11(10):1819-25.

Supplemental Content

Support Center